Technical Analysis for CAPR - Capricor Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 3.09 8.42% 0.24
CAPR closed up 8.42 percent on Friday, September 20, 2019, on 13 percent of normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***
2 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical CAPR trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 8.42%
Inside Day Range Contraction 8.42%
Upper Bollinger Band Touch Strength 8.42%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
BB Squeeze Ended Range Expansion 0.00%

Older signals for CAPR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
CAPR Chart by TradingView
Basic chart:
Profile
Capricor Therapeutics, Inc., a biotechnology company, is focused on the development of novel therapeutics to prevent and treat cardiovascular diseases. Its lead product candidates include CAP-1002 and Cenderitide. The company was founded in 2005 and is based in Beverly Hills, California.
Biotechnology Life Sciences Cardiovascular Diseases Regulus Therapeutics Two River
Is CAPR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Sep 20 Neogen Forms Partnership With IGS to Enhance Beef Profile
Sep 19 Medtronic Receives European Nod for Glucose Monitoring System
Sep 17 A Look At Benzinga Pro's Most-Searched Tickers For September 17, 2019
Sep 17 SBGL, LXRX among top premarket gainers
Sep 17 Abbott Partners With Sanofi to Upgrade Diabetes Management
Sep 17 Capricor up 25% premarket ahead of CAP-1002 data presentation
Sep 17 Capricor Therapeutics to Present Results from the HOPE-2 Trial of CAP-1002 in Duchenne Muscular Dystrophy in a Late Breaking Session of the World Muscle Society
Sep 17 Capricor Therapeutics (CAPR) Presents At 21st Annual H.C. Wainwright Global Investment Conference - Slideshow
Sep 11 Baxter's (BAX) Cheetah Acquisition to Aid Patient Monitoring
Sep 6 Capricor Therapeutics to Present at Upcoming Conferences
See more CAPR news...
Indicators
Indicator Value
52 Week High 11.5
52 Week Low 2.3
Average Volume 1,048,689
200-Day Moving Average 4.3696
50-Day Moving Average 3.4928
20-Day Moving Average 2.659
10-Day Moving Average 2.791
Average True Range 0.2664
ADX 15.92
+DI 29.2819
-DI 13.9444
Chandelier Exit (Long, 3 ATRs ) 2.4308
Chandelier Exit (Short, 3 ATRs ) 3.0992
Upper Bollinger Band 3.0415
Lower Bollinger Band 2.2765
Percent B (%b) 1.06
BandWidth 28.770214
MACD Line -0.0729
MACD Signal Line -0.1733
MACD Histogram 0.1004
Fundamentals Value
Market Cap 72.6 Million
Num Shares 23.5 Million
EPS -0.82
Price-to-Earnings (P/E) Ratio -3.77
Price-to-Sales 15.44
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.44
Resistance 3 (R3) 3.40 3.24 3.38
Resistance 2 (R2) 3.24 3.16 3.26 3.36
Resistance 1 (R1) 3.17 3.10 3.21 3.21 3.34
Pivot Point 3.01 3.01 3.03 3.03 3.01
Support 1 (S1) 2.94 2.93 2.98 2.98 2.84
Support 2 (S2) 2.78 2.87 2.80 2.82
Support 3 (S3) 2.71 2.78 2.80
Support 4 (S4) 2.75